Next report date
Report period
Q2 2024
EPS estimate
−0.10CHF
Revenue estimate
—
−0.451CHF
−43.49 MCHF
79.52 M
About Anavex Life Sciences Corp.
Sector
Industry
CEO
Christopher U. Missling
Website
Headquarters
New York
Employees (FY)
40
Founded
2004
FIGI
BBG00LVD76F3
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 12X1 is 7.867 CHF — it has decreased by 66.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ANAVEX LIFE SCIENC stocks are traded under the ticker 12X1.
ANAVEX LIFE SCIENC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
12X1 stock is 196.61% volatile and has beta coefficient of 1.86. Check out the list of the most volatile stocks — is ANAVEX LIFE SCIENC there?
12X1 earnings for the last quarter are −0.11 CHF per share, whereas the estimation was −0.13 CHF resulting in a 18.18% surprise. The estimated earnings for the next quarter are −0.12 CHF per share. See more details about ANAVEX LIFE SCIENC earnings.
Yes, you can track ANAVEX LIFE SCIENC financials in yearly and quarterly reports right on TradingView.
12X1 stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in ANAVEX LIFE SCIENC price.
12X1 net income for the last quarter is −7.26 M CHF, while the quarter before that showed −9.29 M CHF of net income which accounts for 21.86% change. Track more ANAVEX LIFE SCIENC financial stats to get the full picture.
Today ANAVEX LIFE SCIENC has the market capitalization of 273.25 M, it has decreased by 6.84% over the last week.
No, 12X1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 12X1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANAVEX LIFE SCIENC stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 40.00 employees. See our rating of the largest employees — is ANAVEX LIFE SCIENC on this list?
We've gathered analysts' opinions on ANAVEX LIFE SCIENC future price: according to them, 12X1 price has a max estimate of 36.12 CHF and a min estimate of 22.58 CHF. Read a more detailed ANAVEX LIFE SCIENC forecast: see what analysts think of ANAVEX LIFE SCIENC and suggest that you do with its stocks.